(LI) Klepierre - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000121964
Stock: Shopping Centers, Retail Properties, Real Estate, REIT, Commercial Assets
Total Rating 47
Risk 74
Buy Signal -0.49
| Risk 5d forecast | |
|---|---|
| Volatility | 18.3% |
| Relative Tail Risk | -0.52% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.82 |
| Alpha | 13.92 |
| Character TTM | |
|---|---|
| Beta | 0.007 |
| Beta Downside | -0.119 |
| Drawdowns 3y | |
|---|---|
| Max DD | 13.27% |
| CAGR/Max DD | 1.86 |
Description: LI Klepierre March 01, 2026
Klépierre SA (ticker LI) is Europe’s leading shopping-mall REIT, focused exclusively on continental markets. Its portfolio, valued at €20.6 billion as of 30 June 2025, spans more than 70 centres across 10 countries and attracts over 700 million visitors annually. The company is a French SIIC listed on Euronext Paris and is a constituent of the CAC Next 20, EPRA Euro Zone, and several ESG-focused indexes.
Recent performance shows an average occupancy of 94 % and a 2024 adjusted FFO growth of 5.2 % YoY, driven by strong tenant-mix upgrades and rising rental rates. The European retail sector is benefitting from stabilising consumer confidence and a modest rebound in discretionary spending, while low-interest-rate environments continue to support REIT financing costs.
Klépierre’s commitment to sustainability is reflected in its inclusion in MSCI Europe ESG Leaders and FTSE 4Good, with a 2023 carbon-intensity reduction of 18 % versus the baseline year. For a deeper dive into the stock’s valuation and risk profile, consider reviewing ValueRay’s analysis.
Headlines to watch out for
- Occupancy rates in European shopping malls
- Consumer spending trends in continental Europe
- Interest rate changes impact property valuations
- Regulatory changes for European REITs
- Energy costs affect operational expenses
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: 2.09b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.31 > 1.0 |
| NWC/Revenue: -15.38% < 20% (prev -53.71%; Δ 38.33% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.83b > Net Income 2.09b |
| Net Debt (7.96b) to EBITDA (2.93b): 2.72 < 3 |
| Current Ratio: 0.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (323.5m) vs 12m ago 13.01% < -2% |
| Gross Margin: 80.12% > 18% (prev 0.73%; Δ 7939 % > 0.5%) |
| Asset Turnover: 15.62% > 50% (prev 12.98%; Δ 2.64% > 0%) |
| Interest Coverage Ratio: 15.57 > 6 (EBITDA TTM 2.93b / Interest Expense TTM 186.1m) |
Altman Z'' 1.17
| A: -0.02 (Total Current Assets 1.11b - Total Current Liabilities 1.62b) / Total Assets 22.27b |
| B: 0.03 (Retained Earnings 617.6m / Total Assets 22.27b) |
| C: 0.14 (EBIT TTM 2.90b / Avg Total Assets 21.18b) |
| D: 0.30 (Book Value of Equity 3.24b / Total Liabilities 10.80b) |
| Altman-Z'' Score: 1.17 = BB |
Beneish M -3.12
| DSRI: 0.74 (Receivables 282.7m/299.7m, Revenue 3.31b/2.61b) |
| GMI: 0.91 (GM 80.12% / 73.07%) |
| AQI: 1.00 (AQ_t 0.95 / AQ_t-1 0.95) |
| SGI: 1.27 (Revenue 3.31b / 2.61b) |
| TATA: 0.01 (NI 2.09b - CFO 1.83b) / TA 22.27b) |
| Beneish M-Score: -3.12 (Cap -4..+1) = AA |
What is the price of LI shares?
As of March 09, 2026, the stock is trading at EUR 33.10 with a total of 847,690 shares traded.
Over the past week, the price has changed by -4.21%, over one month by +3.79%, over three months by +2.98% and over the past year by +15.54%.
Over the past week, the price has changed by -4.21%, over one month by +3.79%, over three months by +2.98% and over the past year by +15.54%.
Is LI a buy, sell or hold?
Klepierre has no consensus analysts rating.
What are the forecasts/targets for the LI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 35.9 | 8.4% |
| Analysts Target Price | - | - |
LI Fundamental Data Overview March 08, 2026
Market Cap USD = 10.91b (9.48b EUR * 1.1513 EUR.USD)
P/E Trailing = 8.0535
P/E Forward = 12.2249
P/S = 5.4363
P/B = 1.1336
P/EG = 9.6715
Revenue TTM = 3.31b EUR
EBIT TTM = 2.90b EUR
EBITDA TTM = 2.93b EUR
Long Term Debt = 6.22b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 1.62b EUR (from shortTermDebt, last quarter)
Debt = 8.79b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.96b EUR (from netDebt column, last quarter)
Enterprise Value = 17.44b EUR (9.48b + Debt 8.79b - CCE 831.9m)
Interest Coverage Ratio = 15.57 (Ebit TTM 2.90b / Interest Expense TTM 186.1m)
EV/FCF = 13.52x (Enterprise Value 17.44b / FCF TTM 1.29b)
FCF Yield = 7.40% (FCF TTM 1.29b / Enterprise Value 17.44b)
FCF Margin = 39.00% (FCF TTM 1.29b / Revenue TTM 3.31b)
Net Margin = 63.13% (Net Income TTM 2.09b / Revenue TTM 3.31b)
Gross Margin = 80.12% ((Revenue TTM 3.31b - Cost of Revenue TTM 657.5m) / Revenue TTM)
Gross Margin QoQ = 89.60% (prev 77.03%)
Tobins Q-Ratio = 0.78 (Enterprise Value 17.44b / Total Assets 22.27b)
Interest Expense / Debt = 2.12% (Interest Expense 186.1m / Debt 8.79b)
Taxrate = 13.24% (109.8m / 828.8m)
NOPAT = 2.51b (EBIT 2.90b * (1 - 13.24%))
Current Ratio = 0.69 (Total Current Assets 1.11b / Total Current Liabilities 1.62b)
Debt / Equity = 0.94 (Debt 8.79b / totalStockholderEquity, last quarter 9.32b)
Debt / EBITDA = 2.72 (Net Debt 7.96b / EBITDA 2.93b)
Debt / FCF = 6.17 (Net Debt 7.96b / FCF TTM 1.29b)
Total Stockholder Equity = 8.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.86% (Net Income 2.09b / Total Assets 22.27b)
RoE = 24.13% (Net Income TTM 2.09b / Total Stockholder Equity 8.65b)
RoCE = 19.48% (EBIT 2.90b / Capital Employed (Equity 8.65b + L.T.Debt 6.22b))
RoIC = 15.27% (NOPAT 2.51b / Invested Capital 16.46b)
WACC = 3.97% (E(9.48b)/V(18.27b) * Re(5.94%) + D(8.79b)/V(18.27b) * Rd(2.12%) * (1-Tc(0.13)))
Discount Rate = 5.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 6.31%
[DCF] Terminal Value 87.58% ; FCFF base≈1.21b ; Y1≈1.39b ; Y5≈1.94b
[DCF] Fair Price = 171.0 (EV 56.91b - Net Debt 7.96b = Equity 48.95b / Shares 286.3m; r=5.90% [WACC]; 5y FCF grow 17.09% → 2.90% )
EPS Correlation: 1.93 | EPS CAGR: -42.70% | SUE: 0.0 | # QB: 0
Revenue Correlation: 51.00 | Revenue CAGR: 53.30% | SUE: 0.96 | # QB: 1
EPS current Year (2026-12-31): EPS=2.78 | Chg7d=+0.009 | Chg30d=+0.009 | Revisions Net=+2 | Growth EPS=+2.1% | Growth Revenue=+4.0%
EPS next Year (2027-12-31): EPS=2.83 | Chg7d=+0.002 | Chg30d=+0.002 | Revisions Net=+2 | Growth EPS=+2.1% | Growth Revenue=+2.1%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -4.5% (Discount Rate 7.9% - Earnings Yield 12.4%)
[Growth] Growth Spread = +6.5% (Analyst 2.1% - Implied -4.5%)
P/E Trailing = 8.0535
P/E Forward = 12.2249
P/S = 5.4363
P/B = 1.1336
P/EG = 9.6715
Revenue TTM = 3.31b EUR
EBIT TTM = 2.90b EUR
EBITDA TTM = 2.93b EUR
Long Term Debt = 6.22b EUR (from longTermDebt, two quarters ago)
Short Term Debt = 1.62b EUR (from shortTermDebt, last quarter)
Debt = 8.79b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.96b EUR (from netDebt column, last quarter)
Enterprise Value = 17.44b EUR (9.48b + Debt 8.79b - CCE 831.9m)
Interest Coverage Ratio = 15.57 (Ebit TTM 2.90b / Interest Expense TTM 186.1m)
EV/FCF = 13.52x (Enterprise Value 17.44b / FCF TTM 1.29b)
FCF Yield = 7.40% (FCF TTM 1.29b / Enterprise Value 17.44b)
FCF Margin = 39.00% (FCF TTM 1.29b / Revenue TTM 3.31b)
Net Margin = 63.13% (Net Income TTM 2.09b / Revenue TTM 3.31b)
Gross Margin = 80.12% ((Revenue TTM 3.31b - Cost of Revenue TTM 657.5m) / Revenue TTM)
Gross Margin QoQ = 89.60% (prev 77.03%)
Tobins Q-Ratio = 0.78 (Enterprise Value 17.44b / Total Assets 22.27b)
Interest Expense / Debt = 2.12% (Interest Expense 186.1m / Debt 8.79b)
Taxrate = 13.24% (109.8m / 828.8m)
NOPAT = 2.51b (EBIT 2.90b * (1 - 13.24%))
Current Ratio = 0.69 (Total Current Assets 1.11b / Total Current Liabilities 1.62b)
Debt / Equity = 0.94 (Debt 8.79b / totalStockholderEquity, last quarter 9.32b)
Debt / EBITDA = 2.72 (Net Debt 7.96b / EBITDA 2.93b)
Debt / FCF = 6.17 (Net Debt 7.96b / FCF TTM 1.29b)
Total Stockholder Equity = 8.65b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.86% (Net Income 2.09b / Total Assets 22.27b)
RoE = 24.13% (Net Income TTM 2.09b / Total Stockholder Equity 8.65b)
RoCE = 19.48% (EBIT 2.90b / Capital Employed (Equity 8.65b + L.T.Debt 6.22b))
RoIC = 15.27% (NOPAT 2.51b / Invested Capital 16.46b)
WACC = 3.97% (E(9.48b)/V(18.27b) * Re(5.94%) + D(8.79b)/V(18.27b) * Rd(2.12%) * (1-Tc(0.13)))
Discount Rate = 5.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 6.31%
[DCF] Terminal Value 87.58% ; FCFF base≈1.21b ; Y1≈1.39b ; Y5≈1.94b
[DCF] Fair Price = 171.0 (EV 56.91b - Net Debt 7.96b = Equity 48.95b / Shares 286.3m; r=5.90% [WACC]; 5y FCF grow 17.09% → 2.90% )
EPS Correlation: 1.93 | EPS CAGR: -42.70% | SUE: 0.0 | # QB: 0
Revenue Correlation: 51.00 | Revenue CAGR: 53.30% | SUE: 0.96 | # QB: 1
EPS current Year (2026-12-31): EPS=2.78 | Chg7d=+0.009 | Chg30d=+0.009 | Revisions Net=+2 | Growth EPS=+2.1% | Growth Revenue=+4.0%
EPS next Year (2027-12-31): EPS=2.83 | Chg7d=+0.002 | Chg30d=+0.002 | Revisions Net=+2 | Growth EPS=+2.1% | Growth Revenue=+2.1%
[Analyst] Revisions Ratio: +0.50 (3 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = -4.5% (Discount Rate 7.9% - Earnings Yield 12.4%)
[Growth] Growth Spread = +6.5% (Analyst 2.1% - Implied -4.5%)